FDA Approved: CASPOFUNGIN ACETATE — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for Caspofungin acetate submitted by Sagent Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Esophageal Candidiasis
• Invasive Candidiasis

Drugs mentioned

• Caspofungin Acetate (caspofungin acetate)

Snippet

SUPPL AP for CASPOFUNGIN ACETATE (CASPOFUNGIN ACETATE)